Technical Analysis for OSIR - Osiris Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 14.08 4.53% 0.61
OSIR closed up 4.53 percent on Tuesday, December 11, 2018, on 7.21 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical OSIR trend table...

Date Alert Name Type % Chg
Dec 11 New 52 Week Closing High Bullish 0.00%
Dec 11 Pocket Pivot Bullish Swing Setup 0.00%
Dec 11 Volume Surge Other 0.00%
Dec 11 New 52 Week High Strength 0.00%
Dec 11 Upper Bollinger Band Walk Strength 0.00%
Dec 11 Wide Bands Range Expansion 0.00%
Dec 11 Above Upper BB Strength 0.00%
Dec 11 Overbought Stochastic Strength 0.00%
Dec 11 Upper Bollinger Band Touch Strength 0.00%
Dec 10 Upper Bollinger Band Walk Strength 4.53%

Older signals for OSIR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Osiris Therapeutics, Inc. is a cellular and regenerative medicine company. The Company is focused on researching, developing and marketing products in the wound, orthopedic, and sports medicine markets. The Company operates through Biosurgery business segment, which focuses on products for wound care, orthopedics, and sports medicine to harness the ability of cells and novel constructs to promote the body's natural healing. The Company's products include Grafix, Stravix, TruSkin, Cartiform and BIO4. The Company produces and distributes Grafix for acute and chronic wounds; Stravix for tendon repair; TruSkin for wound closure; Cartiform, a viable cartilage mesh for cartilage repair, and BIO4 for bone growth. The Company's BioSmart cryopreservation process retains the native characteristics and inherent functionality of tissue. Its BioSmart process includes preservation of the three dimensional (3D) matrix, endogenous growth factors, and tissue-resident cells.
Is OSIR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.25
52 Week Low 7.3
Average Volume 62,684
200-Day Moving Average 0.0
50-Day Moving Average 10.8214
20-Day Moving Average 11.606
10-Day Moving Average 12.601
Average True Range 0.5469
ADX 40.11
+DI 42.0753
-DI 6.3599
Chandelier Exit (Long, 3 ATRs ) 12.6093
Chandelier Exit (Short, 3 ATRs ) 11.5407
Upper Bollinger Band 13.9042
Lower Bollinger Band 9.3078
Percent B (%b) 1.04
BandWidth 39.603653
MACD Line 0.8186
MACD Signal Line 0.5449
MACD Histogram 0.2737
Fundamentals Value
Market Cap 485.09 Million
Num Shares 34.5 Million
EPS 0.04
Price-to-Earnings (P/E) Ratio 352.00
Price-to-Sales 1.89
Price-to-Book 2.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.06
Resistance 3 (R3) 15.00 14.63 14.89
Resistance 2 (R2) 14.63 14.38 14.65 14.84
Resistance 1 (R1) 14.35 14.22 14.49 14.41 14.78
Pivot Point 13.98 13.98 14.05 14.00 13.98
Support 1 (S1) 13.70 13.73 13.84 13.76 13.38
Support 2 (S2) 13.33 13.57 13.35 13.32
Support 3 (S3) 13.05 13.33 13.27
Support 4 (S4) 13.11